milnacipran has been researched along with Cognition Disorders in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Banerjee, P; Morilak, DA; Naegeli, KJ; O'Connor, JA | 1 |
| Chen, W; Clauw, DJ; Gendreau, RM; Kranzler, J; Mease, PJ; Palmer, RH; Rao, SG | 1 |
| Chwieduk, CM; McCormack, PL | 1 |
| Clauw, DJ; Geisser, ME; Gendreau, MR; Palmer, R; Strand, V; Williams, DA | 1 |
| Dundon, K; Mease, PJ; Sarzi-Puttini, P | 1 |
| Asada, T; Ohta, H; Sato, S; Terashima, Y; Yamakawa, Y | 1 |
1 review(s) available for milnacipran and Cognition Disorders
| Article | Year |
|---|---|
Pharmacotherapy of fibromyalgia.
Topics: Analgesics; Chronic Pain; Clinical Trials as Topic; Cognition Disorders; Cyclopropanes; Duloxetine Hydrochloride; Fatigue; Fibromyalgia; gamma-Aminobutyric Acid; Humans; Milnacipran; Mood Disorders; Pain Management; Pregabalin; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Syndrome; Thiophenes; Treatment Outcome | 2011 |
3 trial(s) available for milnacipran and Cognition Disorders
| Article | Year |
|---|---|
The efficacy and safety of milnacipran for treatment of fibromyalgia. a randomized, double-blind, placebo-controlled trial.
Topics: Adrenergic Uptake Inhibitors; Adult; Cognition Disorders; Cyclopropanes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fatigue Syndrome, Chronic; Female; Fibromyalgia; Headache; Humans; Male; Middle Aged; Milnacipran; Muscle, Skeletal; Nausea; Pain Measurement; Placebos; Selective Serotonin Reuptake Inhibitors; Treatment Outcome | 2009 |
Contributions of change in clinical status parameters to Patient Global Impression of Change (PGIC) scores among persons with fibromyalgia treated with milnacipran.
Topics: Activities of Daily Living; Adult; Cognition Disorders; Cyclopropanes; Depressive Disorder; Drug Resistance; Female; Fibromyalgia; Humans; Male; Middle Aged; Milnacipran; Outcome Assessment, Health Care; Pain Measurement; Patient Satisfaction; Quality of Life; Selective Serotonin Reuptake Inhibitors; Sleep Wake Disorders; Treatment Outcome | 2010 |
Efficacy of milnacipran on cognitive dysfunction with post-stroke depression: preliminary open-label study.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cognition Disorders; Cyclopropanes; Depressive Disorder; Depressive Disorder, Major; Female; Functional Laterality; Humans; Male; Middle Aged; Milnacipran; Mood Disorders; Psychiatric Status Rating Scales; Stroke; Tomography, X-Ray Computed | 2006 |
2 other study(ies) available for milnacipran and Cognition Disorders
| Article | Year |
|---|---|
Effects of milnacipran on cognitive flexibility following chronic stress in rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cognition Disorders; Cyclopropanes; Desipramine; Male; Milnacipran; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Stress, Psychological | 2013 |
Milnacipran: in fibromyalgia.
Topics: Animals; Bronchodilator Agents; Cognition Disorders; Cyclopropanes; Disease Models, Animal; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Fibromyalgia; Humans; Meta-Analysis as Topic; Milnacipran; Muscle Relaxants, Central; Muscle, Skeletal; Nausea; Norepinephrine; Pain; Pain Measurement; Patient Compliance; Patient Satisfaction; Placebos; Sex Factors; Time Factors; Treatment Outcome | 2010 |